Imaging modalities in synchronous oligometastatic prostate cancer-Reference-Cited by-同舟云学术

Imaging modalities in synchronous oligometastatic prostate cancer

Published:2018-08-01 Issue:12 Volume:37 Page:2573-2583
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Futterer Jurgen J., ,Surcel Cristian,van den Bergh Roderick,Borgmann Hendrik,Briganti Alberto,Gandaglia Giorgio,Kretschmer Alexander,Ost Piet,Sooriakumaran Prasanna,Tilki Derya,Valerio Massimo,Ploussard Guillaume,De Visschere Pieter J. L.,Tsaur Igor

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-018-2416-2.pdf

Reference68 articles.

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403

2. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629

3. Ahmad AE, Leao R, Hamilton RJ (2017) Radical prostatectomy for patients with oligometastatic prostate cancer. Oncology (Williston Park) 31(11):794–802

4. Huggins C, Hodges CV (2002) Studies on prostatic cancer: I. the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168(1):9–12

5. Lorente D, De Bono JS (2014) Molecular alterations and emerging targets in castration resistant prostate cancer. Eur J Cancer 50(4):753–764

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer;Cancer/Radiothérapie;2024-02

2. Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer;European Urology;2022-11

3. First experiment study in cytoreductive prostatectomy in patients with oligo-metastatic prostate cancer following neoadjuvant chemohormonotherapy;Cancer Urology;2021-07-25

4. Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?;Urologic Oncology: Seminars and Original Investigations;2021-07

5. A narrative review of oligometastatic prostate cancer—an evolving paradigm;Annals of Palliative Medicine;2021-03